A suplementação de Ômega-3 em pacientes com Transtorno do Déficit de Atenção e Hiperatividade

Detalhes bibliográficos
Autor(a) principal: Alves de Andrade, Naysa Gabrielly
Data de Publicação: 2024
Outros Autores: Oliveira, Ana Carolina, de Oliveira Baptista Savariego, Bárbara, Sampaio de Araújo , Bianca Mayara, Rodrigues de Castro, Fabrício Augusto, Oliveira de Azevedo , Guilherme, de Oliveira Coimbra, Jessica, Arruda da Silva Cabral Chaves, Manoella Lorena, Pereira de Araújo, Maria Zilda, de Steffani Basso, Orisson, Rocha Gonçalves, Rafael, de Souza Alves Maia, Sophia
Tipo de documento: Artigo
Idioma: por
Título da fonte: Brazilian Journal of Implantology and Health Sciences
Texto Completo: https://bjihs.emnuvens.com.br/bjihs/article/view/1906
Resumo: Attention Deficit Hyperactivity Disorder (ADHD) is a prevalent neurobehavioral disorder, impacting both children and adults. This integrative review highlights the importance of omega-3 fatty acids, especially EPA and DHA, in brain health and ADHD management.   The reviewed literature emphasizes the crucial role of diet in brain development, with adequate omega-3 intake associated with improved cognitive and behavioral function. Clinical studies demonstrate that omega-3 supplementation can reduce ADHD symptoms, especially hyperactivity, impulsivity, and inattention.   While omega-3 supplementation offers promising benefits for ADHD management, questions regarding dosage and treatment duration are still debated. While some recommendations suggest specific doses for pregnant and lactating women, there are variations in international guidelines. Additionally, the effectiveness of supplementation appears to depend on the dose and ratio of EPA and DHA administered.   Therefore, although the findings presented in this review offer valuable insights for clinical practice, further research is needed to establish clear dosage and treatment duration guidelines. This highlights the importance of an individualized approach in the diagnosis and treatment of ADHD, considering the potential benefits of omega-3 supplementation.
id GOE-1_7bf10bba8889a3dd8b8e53a9cf36c309
oai_identifier_str oai:ojs.bjihs.emnuvens.com.br:article/1906
network_acronym_str GOE-1
network_name_str Brazilian Journal of Implantology and Health Sciences
repository_id_str
spelling A suplementação de Ômega-3 em pacientes com Transtorno do Déficit de Atenção e HiperatividadeTranstorno do Déficit de Atenção e HiperatividadeÁcidos Graxos Ômega-3NeurodesenvolvimentoSuplementação DietéticaAttention Deficit Hyperactivity Disorder (ADHD) is a prevalent neurobehavioral disorder, impacting both children and adults. This integrative review highlights the importance of omega-3 fatty acids, especially EPA and DHA, in brain health and ADHD management.   The reviewed literature emphasizes the crucial role of diet in brain development, with adequate omega-3 intake associated with improved cognitive and behavioral function. Clinical studies demonstrate that omega-3 supplementation can reduce ADHD symptoms, especially hyperactivity, impulsivity, and inattention.   While omega-3 supplementation offers promising benefits for ADHD management, questions regarding dosage and treatment duration are still debated. While some recommendations suggest specific doses for pregnant and lactating women, there are variations in international guidelines. Additionally, the effectiveness of supplementation appears to depend on the dose and ratio of EPA and DHA administered.   Therefore, although the findings presented in this review offer valuable insights for clinical practice, further research is needed to establish clear dosage and treatment duration guidelines. This highlights the importance of an individualized approach in the diagnosis and treatment of ADHD, considering the potential benefits of omega-3 supplementation.O Transtorno do Déficit de Atenção e Hiperatividade (TDAH) é um distúrbio neurocomportamental prevalente, impactando tanto crianças quanto adultos. Esta revisão integrativa destaca a importância dos ácidos graxos ômega-3, especialmente o EPA e o DHA, na saúde cerebral e no manejo do TDAH. A literatura revisada enfatiza o papel fundamental da dieta no desenvolvimento cerebral, com a ingestão adequada de ômega-3 associada à melhoria da função cognitiva e comportamental. Estudos clínicos demonstram que a suplementação de ômega-3 pode reduzir os sintomas do TDAH, especialmente hiperatividade, impulsividade e desatenção. Embora a suplementação de ômega-3 ofereça benefícios promissores para o manejo do TDAH, questões sobre dosagem e duração do tratamento ainda estão em debate. Enquanto algumas recomendações sugerem doses específicas para gestantes e lactantes, há variações nas diretrizes internacionais. Além disso, a eficácia da suplementação parece depender da dose e proporção de EPA e DHA administradas. Portanto, embora os resultados apresentados nesta revisão ofereçam insights valiosos para a prática clínica, são necessárias mais pesquisas para estabelecer diretrizes claras de dosagem e duração do tratamento. Isso destaca a importância de uma abordagem individualizada no diagnóstico e tratamento do TDAH, considerando os benefícios potenciais da suplementação de ômega-3.Specialized Dentistry Group2024-04-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://bjihs.emnuvens.com.br/bjihs/article/view/190610.36557/2674-8169.2024v6n4p1200-1216Brazilian Journal of Implantology and Health Sciences ; Vol. 6 No. 4 (2024): BJIHS QUALIS B3 - IMPACT FACTOR SJIF 5.807; 1200-1216Brazilian Journal of Implantology and Health Sciences ; Vol. 6 Núm. 4 (2024): BJIHS QUALIS B3 - FATOR DE IMPACTO SJIF 5.807; 1200-1216Brazilian Journal of Implantology and Health Sciences ; v. 6 n. 4 (2024): BJIHS QUALIS B3 - FATOR DE IMPACTO SJIF 5.807; 1200-12162674-8169reponame:Brazilian Journal of Implantology and Health Sciencesinstname:Grupo de Odontologia Especializada (GOE)instacron:GOEporhttps://bjihs.emnuvens.com.br/bjihs/article/view/1906/2126Copyright (c) 2024 Naysa Gabrielly Alves de Andrade, Ana Carolina Oliveira, Bárbara de Oliveira Baptista Savariego, Bianca Mayara Sampaio de Araújo , Fabrício Augusto Rodrigues de Castro, Guilherme Oliveira de Azevedo , Jessica de Oliveira Coimbra, Manoella Lorena Arruda da Silva Cabral Chaves, Maria Zilda Pereira de Araújo, Orisson de Steffani Basso, Rafael Rocha Gonçalves, Sophia de Souza Alves Maiahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessAlves de Andrade, Naysa GabriellyOliveira, Ana Carolina de Oliveira Baptista Savariego, BárbaraSampaio de Araújo , Bianca Mayara Rodrigues de Castro, Fabrício Augusto Oliveira de Azevedo , Guilherme de Oliveira Coimbra, JessicaArruda da Silva Cabral Chaves, Manoella LorenaPereira de Araújo, Maria Zilda de Steffani Basso, OrissonRocha Gonçalves, Rafaelde Souza Alves Maia, Sophia2024-04-12T20:36:26Zoai:ojs.bjihs.emnuvens.com.br:article/1906Revistahttps://bjihs.emnuvens.com.br/bjihsONGhttps://bjihs.emnuvens.com.br/bjihs/oaijournal.bjihs@periodicosbrasil.com.br2674-81692674-8169opendoar:2024-04-12T20:36:26Brazilian Journal of Implantology and Health Sciences - Grupo de Odontologia Especializada (GOE)false
dc.title.none.fl_str_mv A suplementação de Ômega-3 em pacientes com Transtorno do Déficit de Atenção e Hiperatividade
title A suplementação de Ômega-3 em pacientes com Transtorno do Déficit de Atenção e Hiperatividade
spellingShingle A suplementação de Ômega-3 em pacientes com Transtorno do Déficit de Atenção e Hiperatividade
Alves de Andrade, Naysa Gabrielly
Transtorno do Déficit de Atenção e Hiperatividade
Ácidos Graxos Ômega-3
Neurodesenvolvimento
Suplementação Dietética
title_short A suplementação de Ômega-3 em pacientes com Transtorno do Déficit de Atenção e Hiperatividade
title_full A suplementação de Ômega-3 em pacientes com Transtorno do Déficit de Atenção e Hiperatividade
title_fullStr A suplementação de Ômega-3 em pacientes com Transtorno do Déficit de Atenção e Hiperatividade
title_full_unstemmed A suplementação de Ômega-3 em pacientes com Transtorno do Déficit de Atenção e Hiperatividade
title_sort A suplementação de Ômega-3 em pacientes com Transtorno do Déficit de Atenção e Hiperatividade
author Alves de Andrade, Naysa Gabrielly
author_facet Alves de Andrade, Naysa Gabrielly
Oliveira, Ana Carolina
de Oliveira Baptista Savariego, Bárbara
Sampaio de Araújo , Bianca Mayara
Rodrigues de Castro, Fabrício Augusto
Oliveira de Azevedo , Guilherme
de Oliveira Coimbra, Jessica
Arruda da Silva Cabral Chaves, Manoella Lorena
Pereira de Araújo, Maria Zilda
de Steffani Basso, Orisson
Rocha Gonçalves, Rafael
de Souza Alves Maia, Sophia
author_role author
author2 Oliveira, Ana Carolina
de Oliveira Baptista Savariego, Bárbara
Sampaio de Araújo , Bianca Mayara
Rodrigues de Castro, Fabrício Augusto
Oliveira de Azevedo , Guilherme
de Oliveira Coimbra, Jessica
Arruda da Silva Cabral Chaves, Manoella Lorena
Pereira de Araújo, Maria Zilda
de Steffani Basso, Orisson
Rocha Gonçalves, Rafael
de Souza Alves Maia, Sophia
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Alves de Andrade, Naysa Gabrielly
Oliveira, Ana Carolina
de Oliveira Baptista Savariego, Bárbara
Sampaio de Araújo , Bianca Mayara
Rodrigues de Castro, Fabrício Augusto
Oliveira de Azevedo , Guilherme
de Oliveira Coimbra, Jessica
Arruda da Silva Cabral Chaves, Manoella Lorena
Pereira de Araújo, Maria Zilda
de Steffani Basso, Orisson
Rocha Gonçalves, Rafael
de Souza Alves Maia, Sophia
dc.subject.por.fl_str_mv Transtorno do Déficit de Atenção e Hiperatividade
Ácidos Graxos Ômega-3
Neurodesenvolvimento
Suplementação Dietética
topic Transtorno do Déficit de Atenção e Hiperatividade
Ácidos Graxos Ômega-3
Neurodesenvolvimento
Suplementação Dietética
description Attention Deficit Hyperactivity Disorder (ADHD) is a prevalent neurobehavioral disorder, impacting both children and adults. This integrative review highlights the importance of omega-3 fatty acids, especially EPA and DHA, in brain health and ADHD management.   The reviewed literature emphasizes the crucial role of diet in brain development, with adequate omega-3 intake associated with improved cognitive and behavioral function. Clinical studies demonstrate that omega-3 supplementation can reduce ADHD symptoms, especially hyperactivity, impulsivity, and inattention.   While omega-3 supplementation offers promising benefits for ADHD management, questions regarding dosage and treatment duration are still debated. While some recommendations suggest specific doses for pregnant and lactating women, there are variations in international guidelines. Additionally, the effectiveness of supplementation appears to depend on the dose and ratio of EPA and DHA administered.   Therefore, although the findings presented in this review offer valuable insights for clinical practice, further research is needed to establish clear dosage and treatment duration guidelines. This highlights the importance of an individualized approach in the diagnosis and treatment of ADHD, considering the potential benefits of omega-3 supplementation.
publishDate 2024
dc.date.none.fl_str_mv 2024-04-12
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://bjihs.emnuvens.com.br/bjihs/article/view/1906
10.36557/2674-8169.2024v6n4p1200-1216
url https://bjihs.emnuvens.com.br/bjihs/article/view/1906
identifier_str_mv 10.36557/2674-8169.2024v6n4p1200-1216
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://bjihs.emnuvens.com.br/bjihs/article/view/1906/2126
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Specialized Dentistry Group
publisher.none.fl_str_mv Specialized Dentistry Group
dc.source.none.fl_str_mv Brazilian Journal of Implantology and Health Sciences ; Vol. 6 No. 4 (2024): BJIHS QUALIS B3 - IMPACT FACTOR SJIF 5.807; 1200-1216
Brazilian Journal of Implantology and Health Sciences ; Vol. 6 Núm. 4 (2024): BJIHS QUALIS B3 - FATOR DE IMPACTO SJIF 5.807; 1200-1216
Brazilian Journal of Implantology and Health Sciences ; v. 6 n. 4 (2024): BJIHS QUALIS B3 - FATOR DE IMPACTO SJIF 5.807; 1200-1216
2674-8169
reponame:Brazilian Journal of Implantology and Health Sciences
instname:Grupo de Odontologia Especializada (GOE)
instacron:GOE
instname_str Grupo de Odontologia Especializada (GOE)
instacron_str GOE
institution GOE
reponame_str Brazilian Journal of Implantology and Health Sciences
collection Brazilian Journal of Implantology and Health Sciences
repository.name.fl_str_mv Brazilian Journal of Implantology and Health Sciences - Grupo de Odontologia Especializada (GOE)
repository.mail.fl_str_mv journal.bjihs@periodicosbrasil.com.br
_version_ 1796798447126315008